By Daniella Parra
NanoCell Therapeutics, Inc. has appointed three new members to its Scientific Advisory Board: Prof. Zoltán Ivics, PhD; Jens Hasskarl, MD, PhD; and Jake Brenner, MD, PhD, they said.
NanoCell said the new appointments add critical expertise spanning foundational science, regulatory pathways, and clinical practice as the company advances its platform toward clinical development.
“Drs. Ivics, Hasskarl, and Brenner bring expertise that spans the entire gene therapy development spectrum, from foundational research through commercial success to clinical practice,” said Dr. Maurits Geerlings, CEO and President of NanoCell. “Our team looks forward to working closely with them as we advance NanoCell toward its next milestones.”
READ MORE
New Speakers Announced: 5th Palm Beach CorpGov Forum | Preview Panelists & Topics
Never Miss our Weekly Highlights HERE
